Edition:
United Kingdom

Caroline Humer

CVS to expand health hubs to 1,500 stores by end of 2021

04 Jun 2019

NEW YORK CVS Health Corp said it would offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

CVS to expand health hubs to 1,500 stores by end of 2021

04 Jun 2019

NEW YORK, June 4 CVS Health Corp said it will offer expanded health services such as nutrition counseling and blood pressure screenings in 1,500 stores by the end of 2021, following through on plans announced during the pharmacy chain's 2018 acquisition of health insurer Aetna.

BioMarin says data shows hemophilia gene therapy effects could wane

28 May 2019

BioMarin Pharmaceutical Inc said on Tuesday early trial data for its gene therapy for hemophilia A suggested the one-time infusion's effect on some patients' bleeding disorders would last eight years.

For Anderson family, an early bet on SMA gene therapy

25 May 2019

NEW YORK When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

Novartis $2 million gene therapy for rare disorder is world's most expensive drug

25 May 2019

ZURICH/NEW YORK, Swiss drugmaker Novartis on Friday won U.S. approval for its gene therapy Zolgensma for spinal muscular atrophy (SMA), the leading genetic cause of death in infants, and priced the one-time treatment at a record $2.125 million. | Video

For Anderson family, an early bet on SMA gene therapy

24 May 2019

NEW YORK When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

For Anderson family, an early bet on SMA gene therapy

24 May 2019

NEW YORK When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

For Anderson family, an early bet on SMA gene therapy

24 May 2019

NEW YORK, May 24 When Malachi Anderson was diagnosed with a rare and often deadly disease called spinal muscular atrophy (SMA) as an infant nearly four years ago, his parents Tina and Torence had a decision to make.

Novartis CEO plans gene therapy price 'far lower' than $4 million to $5 million range

23 May 2019

BOSTON Novartis AG's top executive said on Wednesday it expects to price its gene therapy for spinal muscular atrophy “far lower” than the $4 million to $5 million figure the Swiss drugmaker has said it could be worth.

U.S. government to require drugmakers to show prices in TV ads

08 May 2019

The Trump administration on Wednesday said it will require drugmakers to disclose the list price of prescription drugs in direct-to-consumer television advertisements, part of the government's efforts to lower costs for U.S. consumers.

World News